CB Insights FundingFlash is the industry’s most comprehensive and real-time daily roundup of companies receiving venture capital, growth equity or angel funding. This morning’s CB Insights FundingFlash highlighted 28 companies who received a total of $171.8 million of financing in the last day and included news of Xenon Arc, a Redmond, Washington-based company.
CB Insights FundingFlash is the industry’s most comprehensive and real-time daily roundup of companies receiving venture capital, growth equity or angel funding. This morning’s CB Insights FundingFlash highlighted 28 companies who received a total of $171.8 million of financing in the last day and included news of Lutonix, a Maple Grove, Minnesota-based company.
CB Insights FundingFlash is the industry’s most comprehensive and real-time daily roundup of companies receiving venture capital, growth equity or angel funding. This morning’s CB Insights FundingFlash highlighted 28 companies who received a total of $171.8 million of financing in the last day and included news of Nano-Terra’s financing, a Cambridge, Massachusetts-based company.
The most popular healthcare and life science company profiles (ranked 6th to 10th) on CB Insights amongst our VC, corporate development, angel investor and investment banking subscribers for November 2010 are given below. Companies ranked 1 to 5 are available only to subscribers who receive comprehensive CB Insights Trends data.
Amira Pharmaceuticals is creating anti-inflammatory agents. Founded in 2005 and headquartered in San Diego, Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of compounds to treat inflammatory disease linked to the phospholipid pathways. Amira has a strategic partnership with GlaxoSmithKline for the development of FLAP (5-lipoxygenase activating protein) inhibitors in respiratory and cardiovascular disease.
Follow us:
